Close Menu

This summer, Germany was ravaged by an E. coli outbreak that sickened 3,500 people and killed 50. Several research groups around the world quickly mobilized their labs to sequence the bug's genome and analyze it, identifying effective treatment options within days. The University of Maryland School of Medicine's David Rasko was one of the American researchers who teamed up with a group from Denmark's Staten Serums Institut to sequence the bacterium and investigate the epidemiology of the outbreak.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.